{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T22:12:07Z","timestamp":1779919927593,"version":"3.53.1"},"reference-count":37,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2015,6,1]],"date-time":"2015-06-01T00:00:00Z","timestamp":1433116800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["thrombosisresearch.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1016\/j.thromres.2015.03.013","type":"journal-article","created":{"date-parts":[[2015,3,15]],"date-time":"2015-03-15T00:01:37Z","timestamp":1426377697000},"page":"1179-1185","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":42,"title":["Antithrombin heparin binding site deficiency: A challenging diagnosis of a not so benign thrombophilia"],"prefix":"10.1016","volume":"135","author":[{"given":"Christelle","family":"Orlando","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Heylen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Willy","family":"Lissens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristin","family":"Jochmans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.thromres.2015.03.013_bb0005","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.5858\/2002-126-1326-AD","article-title":"Antithrombin deficiency: issues in laboratory diagnosis","volume":"11","author":"Kottke-Marchant","year":"2002","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.thromres.2015.03.013_bb0010","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1111\/j.1365-2516.2008.01830.x","article-title":"Inherited antithrombin deficiency: a review","volume":"6","author":"Patnaik","year":"2008","journal-title":"Haemophilia"},{"key":"10.1016\/j.thromres.2015.03.013_bb0015","first-page":"417","article-title":"Factor V Leiden (FV R506Q) in families with inherited antithrombin deficiency","volume":"3","author":"van Boven","year":"1996","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.thromres.2015.03.013_bb0020","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1055\/s-0037-1616525","article-title":"Homozygous antithrombin deficiency type II (99 Leu to Phe mutation) and childhood thromboembolism","volume":"4","author":"Kuhle","year":"2001","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.thromres.2015.03.013_bb0025","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/0049-3848(86)90386-5","article-title":"Bovine or human thrombin in amidolytic at III assays. Influence of heparin cofactor II","volume":"6","author":"Conard","year":"1986","journal-title":"Thromb Res"},{"key":"10.1016\/j.thromres.2015.03.013_bb0030","doi-asserted-by":"crossref","first-page":"4258","DOI":"10.1182\/blood-2006-08-040774","article-title":"Antithrombin Cambridge II (A384S): an underestimated genetic risk factor for venous thrombosis","volume":"10","author":"Corral","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2015.03.013_bb0035","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1111\/j.1751-553X.2011.01307.x","article-title":"The phenotypic and genetic assessment of antithrombin deficiency","volume":"3","author":"Cooper","year":"2011","journal-title":"Int J Lab Hematol"},{"key":"10.1016\/j.thromres.2015.03.013_bb0040","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1136\/jcp.44.6.477","article-title":"Screening for heparin binding variants of antithrombin","volume":"6","author":"Harper","year":"1991","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.thromres.2015.03.013_bb0045","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1182\/blood.V83.1.146.146","article-title":"Antithrombin-Gly 424 Arg: a novel point mutation responsible for type 1 antithrombin deficiency and neonatal thrombosis","volume":"1","author":"Jochmans","year":"1994","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2015.03.013_bb0050","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1538-7836.2006.01753.x","article-title":"International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)","volume":"2","author":"Miyakis","year":"2006","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.thromres.2015.03.013_bb0055","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.thromres.2013.05.012","article-title":"Great discrepancy in antithrombin activity measured using five commercially available functional assays","volume":"1","author":"Javela","year":"2013","journal-title":"Thromb Res"},{"key":"10.1016\/j.thromres.2015.03.013_bb0060","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1111\/j.1538-7836.2007.02395.x","article-title":"Detecting antithrombin deficiency may be a difficult task\u2013more than one test is necessary","volume":"3","author":"Kristensen","year":"2007","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.thromres.2015.03.013_bb0065","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1111\/jth.12364","article-title":"Type II Antithrombin deficiency caused by a founder mutation Pro73Leu in the Finnish population - clinical picture","volume":"11","author":"Puurunen","year":"2013","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.thromres.2015.03.013_bb0070","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1111\/j.1751-553X.2011.01326.x","article-title":"Clinical multicenter evaluation of a new FXa-based Antithrombin assay","volume":"5","author":"Merz","year":"2011","journal-title":"Int J Lab Hematol"},{"key":"10.1016\/j.thromres.2015.03.013_bb0075","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1309\/AJCPVY4Z9XZMFOTH","article-title":"The superiority of anti-FXa assay over anti-FIIa assay in detecting heparin-binding site antithrombin deficiency","volume":"5","author":"Kovacs","year":"2013","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.thromres.2015.03.013_bb0080","first-page":"231","article-title":"An antithrombin III assay based on factor Xa inhibition provides a more reliable test to identify congenital antithrombin III deficiency than an assay based on thrombin inhibition","volume":"3","author":"Demers","year":"1993","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.thromres.2015.03.013_bb0085","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/ijlh.12219","article-title":"Laboratory testing issues for protein C, protein S, and antithrombin","volume":"3","author":"Marlar","year":"2014","journal-title":"Int J Lab Hematol"},{"key":"10.1016\/j.thromres.2015.03.013_bb0090","doi-asserted-by":"crossref","first-page":"11073","DOI":"10.1016\/S0021-9258(19)68557-1","article-title":"Binding of high affinity heparin to antithrombin III. Stopped flow kinetic studies of the binding interaction","volume":"21","author":"Olson","year":"1981","journal-title":"J Biol Chem"},{"key":"10.1016\/j.thromres.2015.03.013_bb0095","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1182\/blood.V69.5.1275.1275","article-title":"Heparin binding defect in a new antithrombin III variant: Rouen, 47 Arg to His","volume":"5","author":"Owen","year":"1987","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2015.03.013_bb0100","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1182\/blood-2001-11-0047","article-title":"Discrepancy between antithrombin activity methods revealed in Antithrombin Stockholm: do factor Xa-based methods overestimate antithrombin activity in some patients?","volume":"6","author":"Ungerstedt","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2015.03.013_bb0105","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1182\/blood.V79.6.1428.1428","article-title":"Antithrombin-III-Stockholm: a codon 392 (Gly\u2013\u2013Asp) mutation with normal heparin binding and impaired serine protease reactivity","volume":"6","author":"Blajchman","year":"1992","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2015.03.013_bb0110","first-page":"1094","article-title":"Different prevalence of thromboembolism in the subtypes of congenital antithrombin III deficiency: review of 404 cases","volume":"4","author":"Finazzi","year":"1987","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.thromres.2015.03.013_bb0115","first-page":"121","article-title":"The relationship between defective heparin cofactor activities and thrombotic phenomena in AT III abnormalities","volume":"1","author":"Girolami","year":"1988","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.thromres.2015.03.013_bb0120","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1002\/humu.1380040105","article-title":"(ATT) trinucleotide repeats in the antithrombin gene and their use in determining the origin of repeated mutations","volume":"1","author":"Olds","year":"1994","journal-title":"Hum Mutat"},{"key":"10.1016\/j.thromres.2015.03.013_bb0125","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/0014-5793(92)80854-A","article-title":"Antithrombin Budapest 3. An antithrombin variant with reduced heparin affinity resulting from the substitution L99F","volume":"3","author":"Olds","year":"1992","journal-title":"FEBS Lett"},{"key":"10.1016\/j.thromres.2015.03.013_bb0130","doi-asserted-by":"crossref","first-page":"e190","DOI":"10.1097\/MPH.0000000000000033","article-title":"Homozygous Antithrombin Deficiency in Adolescents Presenting With Lower Extremity Thrombosis and Renal Complications: Two Case Reports From Turkey","volume":"36","author":"Sarper","year":"2014","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1016\/j.thromres.2015.03.013_bb0135","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1182\/blood-2012-01-406207","article-title":"Amelioration of the severity of heparin-binding antithrombin mutations by posttranslational mosaicism","volume":"4","author":"Martinez-Martinez","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2015.03.013_bb0140","first-page":"198","article-title":"Homozygous antithrombin deficiency: report of two new cases (99 Leu to Phe) associated with arterial and venous thrombosis","volume":"2","author":"Chowdhury","year":"1994","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.thromres.2015.03.013_bb0145","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1017\/S1047951100009240","article-title":"Pulmonary arterial thrombosis in a neonate with homozygous deficiency of antithrombin III: successful outcome following pulmonary thrombectomy and infusions of antithrombin III concentrate","volume":"3","author":"Roman","year":"2000","journal-title":"Cardiol Young"},{"key":"10.1016\/j.thromres.2015.03.013_bb0150","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1111\/j.1538-7836.2006.01838.x","article-title":"Risk of arterial thrombosis in carriers of familial thrombophilia","volume":"4","author":"Vossen","year":"2006","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.thromres.2015.03.013_bb0155","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1161\/CIRCULATIONAHA.108.780759","article-title":"Hereditary deficiency of protein C or protein S confers increased risk of arterial thromboembolic events at a young age: results from a large family cohort study","volume":"16","author":"Mahmoodi","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.thromres.2015.03.013_bb0160","first-page":"249","article-title":"Impact of the type of SERPINC1 mutation and subtype of antithrombin deficiency on the thrombotic phenotype in hereditary antithrombin deficiency","volume":"2","author":"Luxembourg","year":"2014","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.thromres.2015.03.013_bb0165","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1160\/TH08-09-0583","article-title":"Antithrombin Cambridge II (A384S) supports a role for antithrombin deficiency in arterial thrombosis","volume":"3","author":"Roldan","year":"2009","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.thromres.2015.03.013_bb0170","doi-asserted-by":"crossref","first-page":"4028","DOI":"10.1182\/blood-2003-05-1560","article-title":"Heparin-induced substrate behavior of antithrombin Cambridge II","volume":"12","author":"Mushunje","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2015.03.013_bb0175","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1111\/jth.12243","article-title":"Antithrombin is protective against myocardial ischemia and reperfusion injury","volume":"6","author":"Wang","year":"2013","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.thromres.2015.03.013_bb0180","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1111\/j.1538-7836.2004.00852.x","article-title":"Familial thrombophilia and lifetime risk of venous thrombosis","volume":"9","author":"Vossen","year":"2004","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.thromres.2015.03.013_bb0185","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1111\/j.1538-7836.2005.01197.x","article-title":"Risk of a first venous thrombotic event in carriers of a familial thrombophilic defect. The European Prospective Cohort on Thrombophilia (EPCOT)","volume":"3","author":"Vossen","year":"2005","journal-title":"J Thromb Haemost"}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384815001334?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384815001334?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,7]],"date-time":"2024-06-07T21:18:11Z","timestamp":1717795091000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049384815001334"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6]]},"references-count":37,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015,6]]}},"alternative-id":["S0049384815001334"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2015.03.013","relation":{},"ISSN":["0049-3848"],"issn-type":[{"value":"0049-3848","type":"print"}],"subject":[],"published":{"date-parts":[[2015,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antithrombin heparin binding site deficiency: A challenging diagnosis of a not so benign thrombophilia","name":"articletitle","label":"Article Title"},{"value":"Thrombosis Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.thromres.2015.03.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}